Phase I Trial of an Enhanced Prostate-Specific Antigen–Based Vaccine and Anti–CTLA-4 Antibody in Patients with Metastatic Androgen-Independent Prostate Cancer

Phase I Trial ◽

Specific Antigen ◽

A phase I trial of mushroom powder in patients with biochemically recurrent prostate cancer: Roles of cytokines and myeloid-derived suppressor cells for Agaricus bisporus -induced prostate-specific antigen responses

Cancer ◽

10.1002/cncr.29421 ◽

2015 ◽

Vol 121 (17) ◽

pp. 2942-2950 ◽

Cited By ~ 16

Author(s):

Przemyslaw Twardowski ◽

Noriko Kanaya ◽

Paul Frankel ◽

Timothy Synold ◽

Christopher Ruel ◽

...

Keyword(s):

Prostate Cancer ◽

Phase I ◽

Agaricus Bisporus ◽

Phase I Trial ◽

Specific Antigen ◽

Suppressor Cells ◽

Myeloid Derived Suppressor Cells ◽

Recurrent Prostate Cancer

A Phase I Trial of Intravenous CG7870, a Replication-Selective, Prostate-Specific Antigen–Targeted Oncolytic Adenovirus, for the Treatment of Hormone-Refractory, Metastatic Prostate Cancer

Molecular Therapy ◽

10.1016/j.ymthe.2006.02.011 ◽

2006 ◽

Vol 14 (1) ◽

pp. 107-117 ◽

Cited By ~ 152

Author(s):

Eric J. Small ◽

Michael A. Carducci ◽

James M. Burke ◽

Ron Rodriguez ◽

Lawrence Fong ◽

...

Keyword(s):

Prostate Cancer ◽

Phase I ◽

Metastatic Prostate Cancer ◽

Phase I Trial ◽

Specific Antigen ◽

Oncolytic Adenovirus ◽

Hormone Refractory

A phase I trial of DNA vaccination with a plasmid expressing prostate-specific antigen in patients with hormone-refractory prostate cancer

British Journal of Cancer ◽

10.1038/sj.bjc.6602019 ◽

2004 ◽

Vol 91 (4) ◽

pp. 688-694 ◽

Cited By ~ 122

Author(s):

M Pavlenko ◽

A-K Roos ◽

A Lundqvist ◽

A Palmborg ◽

A M Miller ◽

...

Keyword(s):

Prostate Cancer ◽

Phase I ◽

Phase I Trial ◽

Specific Antigen ◽

Dna Vaccination ◽

Hormone Refractory Prostate Cancer ◽

Hormone Refractory

A Phase I Feasibility Study of an Intraprostatic Prostate-Specific Antigen–Based Vaccine in Patients with Prostate Cancer with Local Failure After Radiation Therapy or Clinical Progression on Androgen-Deprivation Therapy in the Absence of Local Definitive Therapy

Clinical Genitourinary Cancer ◽

10.3816/cgc.2006.n.024 ◽

2006 ◽

Vol 5 (1) ◽

pp. 89-92 ◽

Cited By ~ 4

Author(s):

Jean-Baptiste Lattouf ◽

Philip M. Arlen ◽

Peter A. Pinto ◽

James L. Gulley

Keyword(s):

Prostate Cancer ◽

Radiation Therapy ◽

Phase I ◽

Androgen Deprivation Therapy ◽

Feasibility Study ◽

Specific Antigen ◽

Local Failure ◽

Clinical Progression ◽

Definitive Therapy

Clinical Protocol: Phase I Study of an Adenovirus/Prostate-Specific Antigen Vaccine in Men with Metastatic Prostate Cancer

Human Gene Therapy ◽

10.1089/hum.2006.17.ft-168 ◽

2006 ◽

Vol 0 (0) ◽

pp. 060123080936010

Author(s):

David M. Lubaroff ◽

Badrinath Konety ◽

Brian K. Link ◽

Timothy L. Link ◽

Tammy Madsen ◽

...

Keyword(s):

Prostate Cancer ◽

Phase I ◽

Phase I Study ◽

Metastatic Prostate Cancer ◽

Specific Antigen ◽

Clinical Protocol ◽

Antigen Vaccine

1158. A Phase I/II Dose Escalation Trial of the Intra Prostatic Injection of CG7870, a Prostate Specific Antigen-Dependent Oncolytic Adenovirus in Patients with Locally Recurrent Prostate Cancer Following Definitive Radiotherapy

Molecular Therapy ◽

10.1016/s1525-0016(16)41600-x ◽

2003 ◽

Vol 7 (5) ◽

pp. S446

Keyword(s):

Prostate Cancer ◽

Phase I ◽

Dose Escalation ◽

Specific Antigen ◽

Oncolytic Adenovirus ◽

Recurrent Prostate Cancer ◽

Definitive Radiotherapy ◽

Locally Recurrent

DEVELOPMENT OF PROSTATE-SPECIFIC ANTIGEN PROMOTER-BASED GENE THERAPY FOR ANDROGEN-INDEPENDENT HUMAN PROSTATE CANCER

The Journal of Urology ◽

10.1016/s0022-5347(01)63094-5 ◽

1998 ◽

Vol 160 (1) ◽

pp. 220-229 ◽

Cited By ~ 77

Author(s):

AKINOBU GOTOH ◽

SONG-CHU KO ◽

TOSHIRO SHIRAKAWA ◽

JUN CHEON ◽

CHINGHAI KAO ◽

...

Keyword(s):

Prostate Cancer ◽

Gene Therapy ◽

Specific Antigen ◽

Human Prostate ◽

Human Prostate Cancer ◽

Phase I Trial of 177 Lutetium-Labeled J591, a Monoclonal Antibody to Prostate-Specific Membrane Antigen, in Patients With Androgen-Independent Prostate Cancer

The Journal of Urology ◽

10.1016/s0022-5347(01)68955-9 ◽

2005 ◽

Vol 174 (6) ◽

pp. 2223-2224

Author(s):

Patrick C. Walsh

Keyword(s):

Prostate Cancer ◽

Monoclonal Antibody ◽

Phase I ◽

Phase I Trial ◽

Prostate Specific Membrane Antigen ◽

Specific Membrane ◽

Clinical predictors of androgen-independent prostate cancer and survival in the prostate-specific antigen era

Urology ◽

10.1016/s0090-4295(02)01633-3 ◽

2002 ◽

Vol 60 (1) ◽

pp. 120-124 ◽

Cited By ~ 31

Author(s):

Michael G Oefelein ◽

Vincent S Ricchiuti ◽

P.William Conrad ◽

Howard Goldman ◽

Donald Bodner ◽

...

Keyword(s):

Prostate Cancer ◽

Specific Antigen ◽

Clinical Predictors ◽

The change in free-to-total prostate-specific antigen during progression to androgen-independent state in prostate cancer patients: utilization for intermittent androgen suppression therapy

Prostate Cancer and Prostatic Diseases ◽

10.1038/sj.pcan.4500328 ◽

1999 ◽

Vol 2 (S3) ◽

pp. S2-S2

Author(s):

K Akakura

Keyword(s):

Prostate Cancer ◽

Cancer Patients ◽

Specific Antigen ◽

Independent State ◽

Total Prostate Specific Antigen ◽

Intermittent Androgen Suppression ◽

Androgen Suppression ◽